GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Heron Therapeutics Inc (STU:AXD2) » Definitions » Cyclically Adjusted FCF per Share

Heron Therapeutics (STU:AXD2) Cyclically Adjusted FCF per Share : €-2.40 (As of Mar. 2024)


View and export this data going back to 2015. Start your Free Trial

What is Heron Therapeutics Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Heron Therapeutics's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-0.058. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-2.40 for the trailing ten years ended in Mar. 2024.

During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was -1.10% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 1.90% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 22.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Heron Therapeutics was 43.70% per year. The lowest was -8.10% per year. And the median was 5.70% per year.

As of today (2024-06-01), Heron Therapeutics's current stock price is €3.286. Heron Therapeutics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €-2.40. Heron Therapeutics's Cyclically Adjusted Price-to-FCF of today is .


Heron Therapeutics Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Heron Therapeutics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Heron Therapeutics Cyclically Adjusted FCF per Share Chart

Heron Therapeutics Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -2.44 -2.07 -2.50 -2.64 -2.45

Heron Therapeutics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -2.64 -2.68 -2.43 -2.45 -2.40

Competitive Comparison of Heron Therapeutics's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Heron Therapeutics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Heron Therapeutics's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Heron Therapeutics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Heron Therapeutics's Cyclically Adjusted Price-to-FCF falls into.



Heron Therapeutics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Heron Therapeutics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.058/131.7762*131.7762
=-0.058

Current CPI (Mar. 2024) = 131.7762.

Heron Therapeutics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.387 100.560 -0.507
201409 -0.517 100.428 -0.678
201412 -0.385 99.070 -0.512
201503 -0.629 99.621 -0.832
201506 -0.460 100.684 -0.602
201509 -0.502 100.392 -0.659
201512 -0.597 99.792 -0.788
201603 -0.823 100.470 -1.079
201606 -0.677 101.688 -0.877
201609 -0.835 101.861 -1.080
201612 -0.946 101.863 -1.224
201703 -0.953 102.862 -1.221
201706 -0.538 103.349 -0.686
201709 -0.628 104.136 -0.795
201712 -0.708 104.011 -0.897
201803 -0.785 105.290 -0.982
201806 -0.738 106.317 -0.915
201809 -0.433 106.507 -0.536
201812 -0.416 105.998 -0.517
201903 -0.577 107.251 -0.709
201906 -0.281 108.070 -0.343
201909 -0.277 108.329 -0.337
201912 -0.312 108.420 -0.379
202003 -0.359 108.902 -0.434
202006 -0.568 108.767 -0.688
202009 -0.399 109.815 -0.479
202012 -0.497 109.897 -0.596
202103 -0.393 111.754 -0.463
202106 -0.534 114.631 -0.614
202109 -0.456 115.734 -0.519
202112 -0.396 117.630 -0.444
202203 -0.400 121.301 -0.435
202206 -0.265 125.017 -0.279
202209 -0.335 125.227 -0.353
202212 -0.301 125.222 -0.317
202303 -0.197 127.348 -0.204
202306 -0.212 128.729 -0.217
202309 -0.064 129.860 -0.065
202312 0.013 129.419 0.013
202403 -0.058 131.776 -0.058

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Heron Therapeutics  (STU:AXD2) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Heron Therapeutics Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Heron Therapeutics's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Heron Therapeutics (STU:AXD2) Business Description

Industry
Traded in Other Exchanges
Address
4242 Campus Point Court, Suite 200, San Diego, CA, USA, 92121
Heron Therapeutics Inc is a commercial-stage biotechnology company. It is focused on improving the lives of patients by developing treatments that address some of the unmet patient needs. The company's product portfolio consists of SUSTOL, ZYNRELEF, and CINVANTI. Its pipeline product is HTX-011.

Heron Therapeutics (STU:AXD2) Headlines

No Headlines